Association between antidepressants and the risk of diabetic foot ulcers and amputation in antidepressant-naïve type 2 diabetes mellitus patients: A nested case-control study

Diabetes Res Clin Pract. 2024 Mar:209:111591. doi: 10.1016/j.diabres.2024.111591. Epub 2024 Feb 24.

Abstract

Aims: Antidepressants are widely used by individuals with type 2 diabetes mellitus (T2DM). This study aimed to explore the correlation between antidepressant use, considering specific antidepressant subclasses or cumulative doses, and diabetic foot ulcer (DFU) risk.

Methods: This nested case-control study was conducted using a representative population-based Korean cohort database from 2002 to 2019. Participants with DFUs were matched with participants without DFUs based on age, sex, date of T2DM diagnosis, and follow-up duration. In total, 791 DFUs and 3900 controls were included. The association between antidepressant use or cumulative dose of each antidepressant subclass, DFU risk and amputation risk was examined using a conditional logistic regression model.

Results: Antidepressant ever-use was associated with an increased incidence of DFUs compared with non-use. Furthermore, an increase in DFU risk was evident with increasing cumulative antidepressant dosage, particularly among tricyclic antidepressant (TCA) ever-users and selective serotonin reuptake inhibitors (SSRIs) ever-users. Additionally, antidepressant ever-users displayed a higher risk of DFUs requiring amputation, which was consistently observed when the cumulative dosages of overall antidepressants and TCAs were considered.

Conclusion: Caution is advised when administering TCAs and SSRIs in antidepressant-naïve T2DM patients to reduce DFU and the consequent amputation risk.

Keywords: Amputation; Antidepressant; Diabetes mellitus; Diabetic foot ulcer; Nested case-control.

MeSH terms

  • Amputation, Surgical
  • Antidepressive Agents / adverse effects
  • Case-Control Studies
  • Diabetes Mellitus*
  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / drug therapy
  • Diabetes Mellitus, Type 2* / epidemiology
  • Diabetic Foot* / drug therapy
  • Diabetic Foot* / epidemiology
  • Diabetic Foot* / surgery
  • Humans
  • Risk Factors
  • Selective Serotonin Reuptake Inhibitors / adverse effects

Substances

  • Selective Serotonin Reuptake Inhibitors
  • Antidepressive Agents